-

Wound Dressings Market by Type, Wound Type and End-user - Global Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wound Dressings Market by Type (Traditional, Advanced (Alginate, Collagen, Hydrogel, Foam, Hydrocolloid, Film)), Wound Type (Traumatic, Surgical, Diabetic Foot, Venous Leg Ulcer & Burns), End User (Hospital, ASCs, Homecare) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The wound dressings market is projected to reach USD 11,273.7 million by 2025 from USD 7,091.2 million in 2020, at a CAGR of 9.7%.

The growth of this market is majorly driven by the rising incidence of burn injuries; increasing incidence of chronic, surgical, and traumatic wounds; high rate of cesarean sections in elderly women; and the growing number of road accidents. However, the high cost of advanced wound dressings and the risk factors associated with wound dressings are expected to restrain the growth of this market.

Advanced wound dressings segment accounted for the largest share of the wound dressings market, by type, in 2019

Based on type, the wound dressings market is segmented into traditional wound dressings and advanced wound dressings. The advanced wound dressings segment accounted for the largest share of the wound dressings market, by type, in 2019. This can be attributed to an increase in the incidence of diseases such as diabetic ulcers, venous ulcers, and pressure ulcers. The increasing incidence of diabetes, growing patient awareness, and the rising occurrence of HAIs are also expected to drive the growth of this segment.

Surgical and traumatic wounds segment accounted for the largest share of the wound dressings market, by wound type, in 2019

Based on wound type, the wound dressings market has been segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns, and other wounds. The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed.

Hospitals, ASCs, and clinics segment accounted for the largest share of the wound dressings market, by end-user, in 2019

Based on end-users, the wound dressings market is segmented into hospitals, ASCs, and clinics; home care settings; and other end users. The hospitals, ASCs, and clinics segment accounted for the largest share of the wound dressings market in 2019. This can be attributed to the rising geriatric population and the subsequent increase in the prevalence of age-related conditions and a large number of treatment procedures carried out in hospitals.

North America will continue to dominate the wound dressings market during the forecast period

In 2019, North America accounted for the largest share of the wound dressings market, followed by Europe. The large share of this market can be attributed to the increasing incidence of chronic wounds, rising healthcare expenditure, and the presence of major market players in this region.

Market Dynamics

Drivers

  • Growing Prevalence of Chronic Diseases & Conditions Affecting Wound Healing Capabilities
  • Increasing Spending on Chronic and Surgical Wounds
  • Increasing Number of Road Accidents and Trauma Injuries
  • Technological Advancements in Wound Dressings
  • High Rate of Cesarean Sections in Elderly Mothers

Restraints

  • High Cost of Advanced Wound Dressings
  • Risks Associated With the Use of Wound Dressings

Opportunities

  • Growth Potential in Emerging Economies

Trends

  • Acquisitions by Leading Companies in the Market
  • Focus on Expanding Capabilities of Current Technologies and Launching Novel Products
  • Smart Wound Dressings
  • Crab Shell Bandages
  • Color Changing Dressings
  • Integration of Nanotechnology in Wound Dressings

Challenges

  • Competitive Pricing Pressure

Companies Profiled

  • Smith & Nephew Plc
  • Mlnlycke Health Care Ab
  • Integra Lifesciences Holdings Corporation
  • Convatec Group Plc
  • Coloplast a/S
  • 3M
  • Paul Hartmann Ag
  • B. Braun Melsungen Ag
  • Cardinal Health
  • Advanced Medical Solutions Group Plc
  • Medline Industries, Inc.
  • Lohmann & Rauscher International Gmbh & Co. Kg
  • Hollister Incorporated.
  • Deroyal Industries, Inc.
  • Advancis Medical
  • Urgo Medical
  • Dermarite Industries, Llc
  • Shield Line
  • Winner Medical Co., Ltd.
  • Zeni Medical

For more information about this report visit https://www.researchandmarkets.com/r/rfiewp

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The UAE automotive spare parts e-commerce market, valued at USD 1.2 billion, is experiencing a robust expansion influenced by the surge in online shopping, vehicle ownership, and the need for cost-effective solutions. The convenience provided by e-commerce platforms is r...

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

Disulfiram Market Report 2025-2032: Growth Forecast, Segment Shares, FPNV Positioning Matrix and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The Disulfiram Market is advancing in scope and strategic significance as evolving clinical practices, regulatory shifts, and technology continue to reframe substance use disorder management. Senior executives must navigate opportunities and risks shaped by global healthcare transformation, positioning their organizations for competitive relevance. Market Snap...
Back to Newsroom